The data displays the proportion of oncology spending in the global market by region, in 2010, 2015, and 2016. In 2015, the so-called pharmerging countries spent 13% of thetotal global oncology market spending. Oncology spending remains mostly in the U.S. and the top 5 EU-countries.
United States | 40 | 45 | 46 |
EU-5 | 24 | 20 | 21 |
Rest of world | 14 | 8 | |
Japan | 11 | 8 | 9 |
Pharmerging | 10 | 13 |